It looked like Provenge and SBRT last October had lowered and stabilized my rapidly rising PSA to around 1.8 for three months. Then three weeks ago it mysteriously doubled in a month to 3.1
A new PSMA scan showed four new scattered bone mets appearing since last PSMA scan 3 months prior. Micro mets maturing? I started Xtandi mono therapy ten days ago- but to avoid breast development also added 20 mg Tamoxifen. Ten days later PSA dropped from 3.190 to .910 but hemoglobin also dropped from 11.8 down to 10.3 So although news is both good and bad we are curious as to what happened.
The plan was to use Xtandi mono therapy in order to maintain testosterone so hopefully hemoglobin would rise and PSA would decline. While free of all drugs (Orgovyx, & LU-177) since August, testosterone had slowly rose to 152 then declined then a month later to 135, then 129 and a few days ago dropped to 39.5
Assumption was made that Xtandi blocked cancer receptors but did not lower testosterone. What say the brilliant brethren?